|
| 37513726 | Humanized Mice for Studies of HIV-1 Persistence and Elimination. | | 2023 |
| 36041453 | The potential for treg-enhancing therapies in nervous system pathologies. | Clinical and Experimental Immunology | 2023 |
| 38023614 | Immune senescence in aged APP/PS1 mice. | | 2023 |
| 37813236 | Delivery of gene editing therapeutics. | | 2023 |
| 37964309 | Clinical biomarkers for Lewy body diseases. | | 2023 |
| 37217980 | An open-label multiyear study of sargramostim-treated Parkinson's disease patients examining drug safety, tolerability, and immune biomarkers from limited case numbers. | | 2023 |
| 37027345 | Dual-Peak Lorentzian CEST MRI for antiretroviral drug brain distribution. | | 2023 |
| 36581007 | Multipolymer microsphere delivery of SARS-CoV-2 antigens. | | 2023 |
| 36896351 | Inhibition of matrix metalloproteinases by HIV-1 integrase strand transfer inhibitors. | | 2023 |
| 37451501 | Advances in long-acting slow effective release antiretroviral therapies for treatment and prevention of HIV infection. | | 2023 |
| 37126704 | CRISPR editing of CCR5 and HIV-1 facilitates viral elimination in antiretroviral drug-suppressed virus-infected humanized mice. | | 2023 |
| 36549555 | Development of a porous layer-by-layer microsphere with branched aliphatic hydrocarbon porogens. | | 2023 |
| 35073629 | Oral antivirals for the prevention and treatment of SARS-CoV-2 infection. | AIDS Reviews | 2022 |
| 35658545 | Ultra-long-acting antivirals as chemical vaccines to prevent viral diseases. | Future Microbiology | 2022 |
| 36044375 | Animal models for studies of HIV-1 brain reservoirs. | J Leukoc Biol | 2022 |
| 35760647 | The 2022 outbreak and the pathobiology of the monkeypox virus. | Journal of Autoimmunity | 2022 |
| 35871362 | Therapeutic Strategies for Immune Transformation in Parkinson's Disease. | Journal of Parkinson's Disease | 2022 |
| 35802825 | Monocyte biomarkers define sargramostim treatment outcomes for Parkinson's disease. | Clinical and Translational Medicine | 2022 |
| 35738463 | Development of an extended half-life GM-CSF fusion protein for Parkinson's disease. | Journal of Controlled Release | 2022 |
| 35680875 | Transformation of dolutegravir into an ultra-long-acting parenteral prodrug formulation. | Nature Communications | 2022 |
| 36563152 | An ultralong-acting tenofovir ProTide nanoformulation achieves monthslong HBV suppression. | | 2022 |
| 36558984 | HIV-1 Integrase Strand Transfer Inhibitors and Neurodevelopment. | | 2022 |
| 35335894 | Prodrug Therapies for Infectious and Neurodegenerative Diseases. | Pharmaceutics | 2022 |
| 35312284 | Europium-Doped Cerium Oxide Nanoparticles for Microglial Amyloid Beta Clearance and Homeostasis. | ACS Chemical Neuroscience | 2022 |
| 34985679 | Pathways Toward a Functional HIV-1 Cure: Balancing Promise and Perils of CRISPR Therapy. | Methods in Molecular Biology | 2022 |
| 34728344 | Ultra-long-acting (XLA) antivirals for chronic viral hepatitis. | International Journal of Infectious Diseases | 2022 |
| 34528173 | Recovery of Latent HIV-1 from Brain Tissue by Adoptive Cell Transfer in Virally Suppressed Humanized Mice. | Journal of NeuroImmune Pharmacology | 2021 |
| 33972918 | Europium sulfide nanoprobes predict antiretroviral drug delivery into HIV-1 cell and tissue reservoirs. | Nanotheranostics | 2021 |
| 33544324 | A Role for Extracellular Vesicles in SARS-CoV-2 Therapeutics and Prevention. | Journal of NeuroImmune Pharmacology | 2021 |
| 33589798 | Diagnostics for SARS-CoV-2 infections. | Nature Materials | 2021 |
| 34160586 | The Immunopathobiology of SARS-CoV-2 Infection. | FEMS Microbiology Reviews | 2021 |
| 34049358 | Chemical exchange saturation transfer for detection of antiretroviral drugs in brain tissue. | AIDS | 2021 |
| 34000620 | Safety, tolerability, and immune-biomarker profiling for year-long sargramostim treatment of Parkinson's disease. | eBioMedicine | 2021 |
| 33839625 | Granulocyte-macrophage colony-stimulating factor mRNA and Neuroprotective Immunity in Parkinson's disease. | Biomaterials | 2021 |
| 34268510 | Defining the Immune Responses for SARS-CoV-2-Human Macrophage Interactions. | | 2021 |
| 34103484 | Lipophilic nanocrystal prodrug-release defines the extended pharmacokinetic profiles of a year-long cabotegravir. | Nature Communications | 2021 |
| 33450312 | Efavirenz, atazanavir, and ritonavir disrupt sarcoplasmic reticulum Ca homeostasis in skeletal muscles. | Antiviral Research | 2021 |
| 34090462 | Humanized Mice for Infectious and Neurodegenerative disorders. | Retrovirology | 2021 |
| 33246331 | Alzheimer's disease brain-derived extracellular vesicles spread tau pathology in interneurons. | Brain | 2021 |
| 33428995 | Nanocarrier vaccines for SARS-CoV-2. | Advanced Drug Delivery Reviews | 2021 |
| 33403500 | Pharmacotherapeutics of SARS-CoV-2 Infections. | Journal of NeuroImmune Pharmacology | 2021 |
| 34798897 | CD4+ effector T cells accelerate Alzheimer's disease in mice. | Journal of Neuroinflammation | 2021 |
| 34671355 | Defining the Innate Immune Responses for SARS-CoV-2-Human Macrophage Interactions. | Frontiers in Immunology | 2021 |
| 34390469 | Dolutegravir Inhibition of Matrix Metalloproteinases Affects Mouse Neurodevelopment. | Molecular Neurobiology | 2021 |
| 34970611 | A Link Between Methylglyoxal and Heart Failure During HIV-1 Infection. | Front Cardiovasc Med | 2021 |
| 34774454 | CRISPR-Cas9 Mediated Exonic Disruption for HIV-1 Elimination. | eBioMedicine | 2021 |
| 34826061 | The COVID-19 Pandemic: Reflections of Science, Person, and Challenge in Academic Research Settings. | J Neuroimmune Pharmacol | 2021 |
| 34531390 | Transformation of tenofovir into stable ProTide nanocrystals with long-acting pharmacokinetic profiles. | Nature Communications | 2021 |
| 32638217 | Neuroprotective Activities of Long-Acting Granulocyte-Macrophage Colony-Stimulating Factor (mPDM608) in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Intoxicated Mice. | | 2020 |
| 31742407 | Synthesis and Characterization of Long-Acting Darunavir Prodrugs. | Molecular Pharmaceutics | 2020 |